GMT is written as "GREENWICH MEAN TIME", the omega replica Royal Greenwich Observatory in hublot replica London, England, focusing on replica watch uk the word "GMT" that symbolizes the pursuit of human civilization for the accuracy of time.Albert refers to the first generation of swiss rolex replica GMT no shoulder pads, gold ring on the surface, and black gold (glossy gilt) is more soft. Interview GMT-MASTER Ref. 1675 for the fake watches uk GMT-MASTER third generation, especially the addition of round mouth shoulder pads, the market value of about 72,000 yuan.


For up-to-date news regarding Locate Therapeutics, please visit our Linked-In page.

Locate Therapeutics Deepens Development Collaboration With Heraeus Medical GmbH.

27th Jan 2017.
Nottingham based, Locate Therapeutics (“Locate”) announced today the deepening of a development collaboration with the innovative orthopaedic company, Heraeus Medical GmbH. Full article >

Innovate UK Funding Award for Locate Therapeutics and The University of Nottingham.

11th Feb 2016.
Locate Therapeutics Ltd ("Locate"), the regenerative medicine development company, and the School of Pharmacy at The University of Nottingham, have been awarded a grant from Innovate UK. Full article >

Locate Therapeutics Appoints Chairman.

5th Jan 2015.
Locate Therapeutics Ltd ("Locate"), the regenerative medicine development company, today announced the appointment of Dr Ian Wilding as Chairman of the Board of Directors. Full article >

Heraeus Medical GmbH signs Exclusive License and Development
Agreement with Locate Therapeutics for Orthopaedic Applications

9th Dec 2014.
Wehrheim, December 2014 – Heraeus Medical GmbH announced today an agreement with Locate Therapeutics to license the intellectual property surrounding the use of TAOS® in orthopaedic applications and the inception of the first development program in this field. Full article >

Medilink Supports Pioneering Tissue Repair Technology
Agreement with Locate Therapeutics for Orthopaedic Applications

4th Dec 2014.
Locate Therapeutics Ltd, a Nottingham based specialist regenerative medicine company has been awarded a grant from the Healthcare and Bioscience iNetFull article >

European Patent for Injectable Scaffold Delivery System.

28th Nov 2014.
ocate Therapeutics Ltd ("Locate"), the regenerative medicine and devices company, has received notification that it will be granted a new patent covering its TAOS™ (Tailored Orchestrated Signalling matrix) technology across Europe (European Patent No. 2 125 048). Full article >

Heraeus invests in Locate Therapeutics.

9th May 2014, Hanau, Germany.
Precious metal and technology Group, Heraeus Holding (Heraeus), announced today the completion of an equity investment in Nottingham based regenerative medicine platform company, Locate Therapeutics (Locate). Full article >

For further information please email or call +44 (0)115 784 0041.

Product Development Pipeline
Application Development
Partnering Opportunities

© 2014 Locate Therapeutics Limited.

All rights reserved.

Registered in England number 04202562.

Locate Therapeutics Limited


Thane Road


Nottingham NG90 6BH

United Kingdom


+44 (0)115 784 0041